Premium
Increased memory and decreased naïve T cells in human hypertension (1074.9)
Author(s) -
Marvar Paul,
Cruise Tom,
Hart Emma,
Burchell Amy,
Ratcliffe Laura,
Nightingale Angus,
Paton Julian
Publication year - 2014
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.28.1_supplement.1074.9
Subject(s) - pathogenesis , cd8 , cd3 , flow cytometry , medicine , essential hypertension , immunology , effector , endocrinology , antigen , blood pressure
Studies have revealed a role for pro‐inflammatory effector‐like CD3+ T cells in the pathogenesis of experimental hypertension. Despite these observations, our knowledge of the role that T cells and subsets of T cells (memory vs naïve) play in the development of human hypertension is unknown. We hypothesized that circulating cells of hypertensive patients exhibit a pro‐inflammatory T cell phenotype, as determined by the balance of memory (effector) versus naïve CD3+ cells. Using flow cytometry, subsets of circulating T cells and markers of antigenic memory were analyzed in male hypertensive patients and normotensive subjects. There were no differences in the overall percentage of CD3+ cells in normotensive (63.3 ± 3.7%) (n=5; mean age 34 yrs; mean systolic BP 128.6 mmHg) vs. hypertensive men (62.2 ± 5.5%) (n=6; mean age 53.5 yrs; mean systolic BP 154.7 mmHg). The percentage of CD4+ and CD8+ T cell subsets were not statistically different between groups. Further subset analysis revealed that the ratio (1.6 ± 0.3 vs 0.7 ± 0.1; P <0.05) of memory (CD45RO+CD3+) vs. naïve (CD45RA+CD3+) T cells as well as the percentage of CD8+CD62L(low) cells (70.4 ± 4.5 vs 52.8 ± 6.3; P <0.05) were increased in hypertension. These results demonstrate an imbalance in effector memory / naïve T cells in hypertensive men and provide further evidence that chronic antigen exposure may be involved in the pathogenesis of hypertension. Supported by NIH‐HL107675‐01, Marie Curie‐IIF ‐ 276147 and British Heart Foundation. Grant Funding Source : NIH‐HL107675‐01, Marie Curie‐IIF – 276147 and British Heart Foundation
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom